In addition to diabetes and obesity, emerging data have demonstrated that GLP-1RAs reduce the rates of several other risk factors for PDAC (Fig
Glutathione contains glutathione as the active ingredient, along with standard inactive ingredients used to support stability, accurate dosing, and proper delivery
Frequently Asked Questions What is GLP1 obesity treatment
Nippon Zenyaku Kogyo Co., Ltd., Tokyo, Japan) was used for chemical sympathectomy
This issue of MIND Matters celebrates the people doing this work, including some new members of our team (p 7), the trainees who are acquiring skills and knowledge to lead this work (p 6), the progress being made by investigators (p 5), and an amazing research participant and advocate, Julie Moore (p 1 and 3) who has been recognized for her remarkable leadership
As these exploratory results are descriptive, further research is needed to evaluate the patient and provider-related factors influencing GLP-1 prescribing, access, utilization, and outcomes